How Injectable GHK-Cu Works in Your Body Understanding the mechanisms behind GHK-Cu helps explain both its broad effects and why certain protocols produce better results
The information presented herein reflects publicly available data and affiliate editorial perspectives for research compounds intended solely for laboratory use
The primary outcome measure was the change in the number of satisfactory sexual encounters, as reported through question 10 (Q10) of an adapted questionnaire called the Female Sexual Encounter Profile-Revised (FSEP-R)
Ercal says NACA is an improvement over another experimental treatment, the antioxidant N-acetylcysteine (NAC), because it passes more easily across cell membranes, allowing the medication to be used in lower doses
doi: 10.2147/CCID.S68424
It is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: References Mechanism of Action 1-2 Bremelanotide, a MCR agonist, non-selectively works on several receptor subtypes MC1R-MC5R in the central nervous system